Publication:
Glucagon-like peptide-1 receptor agonists: an emerging hope against nephrolithiasis risk reduction via body weight reduction

Simple item page
dc.contributor.coauthorCovic, Adrian
dc.contributor.coauthorRossing, Peter
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuauthorÇöpür, Sidar
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-02-26T07:11:54Z
dc.date.available2026-02-25
dc.date.issued2026
dc.description.abstractBAKILACAK
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessN/A
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionN/A
dc.identifier.doi10.1007/s11255-025-04997-y
dc.identifier.eissn1573-2584
dc.identifier.embargoNo
dc.identifier.issn0301-1623
dc.identifier.pubmed41484515
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-105026779251
dc.identifier.urihttps://doi.org/10.1007/s11255-025-04997-y
dc.identifier.urihttps://hdl.handle.net/20.500.14288/32434
dc.identifier.wos001653176800001
dc.keywordsObesity
dc.keywordsNephrolithiasis
dc.keywordsHypertension
dc.keywordsDiabetes mellitus
dc.keywordsHyperlipidemia
dc.keywordsHyperuricemia
dc.keywordsCardiovascular events
dc.keywordsCerebrovascular events
dc.keywordsObstructive sleep apnea
dc.keywordsChronic kidney disease
dc.keywordsUrinary oxalate
dc.keywordsUric acid stones
dc.keywordsCalcium oxalate stones
dc.keywordsWeight reduction
dc.keywordsBariatric surgery
dc.keywordsRoux-en-Y gastric bypass
dc.keywordsOrlistat
dc.language.isoeng
dc.publisherSpringer
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofInternational Urology and Nephrology
dc.relation.openaccessNo
dc.rightsCopyrighted
dc.subjectUrology
dc.subjectNephrology
dc.titleGlucagon-like peptide-1 receptor agonists: an emerging hope against nephrolithiasis risk reduction via body weight reduction
dc.typeLetter
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext